Lion's Den 2026
Healthcare Investment Access Program
Ahead of the NAHC, Innovation Norway hosts a Lion’s Den Pitch session, where promising Nordic companies can pitch their science, technology, and commercial potential to a panel of investors and industry leaders.
This year, the Lions Den will support pitches by 2026 Healthcare Investment Access (HIA) companies, including AKIGAI, DoMore Diagnostics, ImmunoQuest Therapeutics, Node Pharma, Rab Diagnostics, ROPCA, Thelper, and Tribune Therapeutics.
HIA companies chosen to present have been selected through an independent, competitive process to join the 2025/2026 HIA program — a year‑long initiative designed to accelerate investor readiness, strengthen global visibility, and support founders as they scale.
HIA spotlights Nordic companies with traction: novel science, differentiated technology, and teams that deliver.
Congratulations and good luck to the 2026 Lion’s Den presenters!
Lion’s Den Program
March 26, 2026
8:00 AM - 9:00 AM
A&O Shearman
Open to registered NAHC attendees
About the Healthcare Investment Access Program
The Healthcare Investment Access (HIA) program is an initiative by DNB Bank in collaboration with Innovation Norway.
For 2025/2026, HIA is powered together with Ergo;ego, Insider Group, Nasdaq, the Norwegian Consulate General in New York, Oslo Cancer Cluster and DNB Carnegie | Back Bay Healthcare.
The program is also supported by Aleap, Biotech North, Eitri, HAI, The Life Science Cluster, Luma Group, Norinnova, Norway Health Tech, the Norwegian Embassy in Bern, and SPARK.
“HIA’s mission is straightforward: shorten the path to investor readiness and help Nordic Healthcare entrepreneurs step confidently onto the global stage.”